A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

Clinical trial NCT07735533 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07735533
Sponsor: Umoja Biopharma
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, B Cell Lymphoma Non-Hodgkin High Grade B Cell Lymphoma Richter Transformation Lymphoma Grade 3b Follicular Lymphoma Primary Mediastinal B Cell Lymphoma Diffuse Large B Cell Lymphoma (DLBCL)

Start date: 2026-08-01
Primary completion: 2031-08-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.